Os01g0141000 Antibody

What is Os01g0141000 and why are antibodies against it valuable for research?

Os01g0141000 (also known as LOC_Os01g04800) is an AP2/ERF and B3 domain-containing protein found in rice (Oryza sativa subsp. japonica). According to protein information databases, it has a molecular weight of approximately 39,280 Da and consists of 365 amino acids . The protein belongs to a family of transcription factors involved in plant development and stress responses.

Recent research suggests this protein may play a role in gibberellic acid (GA) signaling pathways in rice. Anti-OsGAE1 antibodies have been shown to immunoreact with a protein of approximately 40 kDa in rice leaf sheath , consistent with the expected size of Os01g0141000.

Antibodies against Os01g0141000 are valuable research tools for:

• Studying protein expression patterns across different rice tissues and developmental stages

• Investigating its subcellular localization

• Examining its role in plant stress responses and hormone signaling

• Analyzing potential protein-protein interactions

• Understanding its post-translational modifications

How should I validate an Os01g0141000 antibody for specificity in rice samples?

Antibody validation is critical for ensuring experimental reproducibility. For Os01g0141000 antibodies, follow these methodological approaches:

• Genetic validation strategy:

  • Use CRISPR/Cas9-generated Os01g0141000 knockout rice plants as negative controls

  • Compare antibody signals between wild-type and knockout tissues

  • A specific antibody should show signal in wild-type but not in knockout samples

• Orthogonal validation strategy:

  • Compare antibody detection with mRNA expression data (RT-PCR or RNA-seq)

  • Tissues with higher mRNA expression should show stronger antibody signals

  • This correlation supports antibody specificity

• Multiple antibody strategy:

  • Test multiple antibodies targeting different epitopes of Os01g0141000

  • Similar results from independent antibodies increase confidence in specificity

• Recombinant protein controls:

  • Use purified recombinant Os01g0141000 protein as a positive control

  • Verify antibody detection of the recombinant protein

  • Commercial recombinant proteins are available in several expression systems including E. coli, yeast, baculovirus, and mammalian cells

• Immunoprecipitation-mass spectrometry:

  • Use the antibody for immunoprecipitation from rice tissue

  • Analyze precipitated proteins by mass spectrometry

  • Confirm that Os01g0141000 is among the predominant proteins detected

The combination of multiple validation approaches provides the strongest evidence for antibody specificity and reliability.

What experimental conditions should I use for Western blotting with Os01g0141000 antibodies?

Based on the protein's characteristics and general best practices for plant protein detection:

Sample preparation:

• Extract total protein from rice tissues using a buffer containing protease inhibitors

• Include phosphatase inhibitors if studying phosphorylation status

• Determine protein concentration using Bradford or BCA assay

• Prepare samples in standard Laemmli buffer with reducing agent

SDS-PAGE and transfer conditions:

• Use 10-12% polyacrylamide gels (appropriate for a ~40 kDa protein)

• Load 20-50 μg of total protein per lane

• Include molecular weight markers and appropriate controls

• Transfer to PVDF membrane (often preferred for plant proteins)

Antibody incubation:

• Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Dilute primary antibody according to manufacturer's recommendation (typically 1:1000 to 1:2000)

• Incubate with primary antibody overnight at 4°C

• Wash 3-5 times with TBST (5 minutes each)

• Incubate with appropriate HRP-conjugated secondary antibody (1:5000-1:10000) for 1 hour at room temperature

• Wash 3-5 times with TBST

Detection:

• Use enhanced chemiluminescence (ECL) detection reagents

• Expected molecular weight: ~39-40 kDa

• Include a loading control (e.g., actin or GAPDH)

Optimization tips:

• Test a range of antibody dilutions to determine optimal concentration

• If background is high, increase washing steps or add 0.1% Tween-20 to antibody diluent

• For weak signals, consider longer incubation times or signal enhancement systems

What controls should I include when working with Os01g0141000 antibodies?

Proper controls are essential for interpreting antibody-generated data . For Os01g0141000 antibody experiments, include:

Positive controls:

• Recombinant Os01g0141000 protein:

  • Use purified protein as a reference standard

  • Helps confirm antibody binding and proper size detection

  • Available commercially in multiple expression systems

• Tissues with known high expression:

  • Based on transcriptomic data, use rice tissues known to express Os01g0141000

  • These tissues should show consistent antibody signal

• Overexpression samples:

  • Samples from transgenic rice overexpressing Os01g0141000

  • Should show significantly higher signal than wild-type samples

Negative controls:

• Genetic knockouts/knockdowns:

  • CRISPR/Cas9-generated Os01g0141000 knockout rice

  • Should show significantly reduced or absent signal

• Blocking peptide controls:

  • Pre-incubate antibody with excess Os01g0141000 peptide/protein

  • This should block specific binding sites on the antibody

  • Resulting signal represents non-specific binding

• Primary antibody omission:

  • Process samples without primary antibody

  • Reveals background from secondary antibody alone

  • Particularly important for immunohistochemistry

• Isotype controls:

  • Use non-specific antibody of same isotype/host species

  • Controls for non-specific binding due to antibody class

All antibody-generated data should include these controls to ensure reproducibility and reliable interpretation of results .

How can I assess cross-reactivity of Os01g0141000 antibodies with other AP2/ERF domain-containing proteins?

Cross-reactivity assessment is particularly important for antibodies targeting members of protein families with conserved domains, such as the AP2/ERF transcription factors. Use these approaches:

• Sequence alignment analysis:

  • Identify other AP2/ERF domain-containing proteins in rice

  • Align sequences to identify regions of homology

  • Determine if the antibody epitope overlaps with conserved regions

  • Higher epitope conservation suggests greater cross-reactivity potential

• Recombinant protein panel testing:

  • Express recombinant versions of related AP2/ERF proteins

  • Test antibody binding to each protein using Western blot or ELISA

  • Quantify relative binding affinity to each protein

  • Create a cross-reactivity profile as shown in this example:

• Competitive binding assays:

  • Pre-incubate antibody with excess of related proteins

  • Test if this pre-incubation reduces binding to Os01g0141000

  • Reduction in signal indicates cross-reactivity

• Immunoprecipitation-mass spectrometry:

  • Perform IP using the Os01g0141000 antibody

  • Analyze all captured proteins by mass spectrometry

  • Identify any related AP2/ERF proteins that co-precipitate

  • Calculate enrichment ratios of specific vs. non-specific proteins

• Genetic approach:

  • Test antibody in tissues where Os01g0141000 is knocked out but related proteins are expressed

  • Any remaining signal may indicate cross-reactivity

Understanding antibody cross-reactivity is essential for correctly interpreting experimental results, especially when studying protein families with conserved domains.

How do post-translational modifications of Os01g0141000 affect antibody binding and specificity?

Post-translational modifications (PTMs) can significantly impact antibody recognition of target proteins:

• Relevant PTMs for transcription factors like Os01g0141000:

  • Phosphorylation: Regulates DNA binding and protein-protein interactions

  • Ubiquitination: Controls protein stability and turnover

  • SUMOylation: Modulates transcriptional activity

  • Acetylation: Affects DNA binding affinity

• Mechanisms affecting antibody binding:

  • Epitope masking: PTMs can physically block antibody binding sites

  • Conformational changes: PTMs can alter protein structure, affecting epitope accessibility

  • Charge alterations: PTMs can change local charge distribution, affecting antibody affinity

• Methodological approaches to assess PTM impact:

  a) Epitope mapping:

  • Identify the specific epitope recognized by the antibody

  • Determine if the epitope contains potential PTM sites

  • Use bioinformatics to predict likely PTM sites in Os01g0141000

  b) PTM-specific antibodies:

  • Compare signal patterns between pan-specific and PTM-specific antibodies

  • Differences reveal the population of modified protein

  c) Enzymatic treatment:

  • Treat samples with phosphatases, deubiquitinases, or other PTM-removing enzymes

  • Compare antibody binding before and after treatment

  • Changes in signal indicate PTM sensitivity

  d) Immunoprecipitation-mass spectrometry:

  • Immunoprecipitate Os01g0141000 using the antibody

  • Analyze by mass spectrometry to identify PTMs on captured protein

  • Determine if the antibody captures all modified forms or is selective

• PTM impact assessment table:

Understanding how PTMs affect antibody binding is crucial for accurate interpretation of experimental results, especially when studying protein regulation under different conditions.

How can I use Os01g0141000 antibodies to investigate protein-protein interactions?

Several antibody-based techniques can be employed to study Os01g0141000 protein interactions:

• Co-immunoprecipitation (Co-IP):

  • Use Os01g0141000 antibody to pull down the protein and its binding partners

  • Extract proteins under non-denaturing conditions to preserve interactions

  • Analyze precipitated proteins by mass spectrometry or Western blot

  • Benefits: Captures native complexes from plant tissues

  • Limitations: May disrupt weak interactions, requires validation

  Protocol considerations:

  • Use gentle lysis buffers (avoid strong detergents)

  • Include protease inhibitors to prevent degradation

  • Cross-link proteins if interactions are transient

  • Include appropriate controls (IgG control, knockout tissue)

• Proximity-dependent labeling:

  • Create fusion protein of Os01g0141000 with BioID or APEX2

  • Express in rice tissues or protoplasts

  • Enzyme labels proximal proteins for isolation and identification

  • Benefits: Captures transient interactions, works in native context

  • Limitations: Requires genetic modification, may alter protein function

• Bimolecular Fluorescence Complementation (BiFC):

  • Fuse Os01g0141000 and potential partners to split fluorescent protein halves

  • Co-express in rice protoplasts or transgenic plants

  • Interaction brings halves together, restoring fluorescence

  • Benefits: Visualizes interactions in living cells, shows subcellular localization

  • Limitations: Potential false positives, irreversible complex formation

• Förster Resonance Energy Transfer (FRET):

  • Fuse Os01g0141000 and partners to compatible fluorophores

  • Energy transfer occurs when proteins interact

  • Measure by acceptor photobleaching or fluorescence lifetime imaging

  • Benefits: Quantitative, works in living cells, detects dynamic interactions

  • Limitations: Complex instrumentation, careful controls needed

• Antibody-based protein interaction validation approaches:

What techniques are most appropriate for quantifying Os01g0141000 expression levels in different rice tissues?

Several methodologies can be employed for quantitative analysis of Os01g0141000 protein expression:

• Western blotting with quantitative analysis:

  • Uses Os01g0141000-specific antibodies

  • Include calibration curve using recombinant Os01g0141000

  • Use appropriate loading controls (constitutively expressed proteins)

  • Analyze band intensity with software (ImageJ, Image Lab)

  • Benefits: Relatively simple, widely accessible equipment

  • Limitations: Semi-quantitative, may miss post-translational modifications

• Enzyme-linked immunosorbent assay (ELISA):

  • Develop sandwich ELISA using two non-competing Os01g0141000 antibodies

  • Create standard curve with recombinant protein

  • Allows high-throughput analysis of multiple samples

  • Benefits: Truly quantitative, high sensitivity

  • Limitations: Requires development and optimization of assay

• Immunohistochemistry with quantitative image analysis:

  • Allows visualization of spatial distribution in tissues

  • Use consistent staining protocols and imaging parameters

  • Analyze signal intensity using image analysis software

  • Benefits: Maintains tissue context, reveals cell-specific expression

  • Limitations: Semi-quantitative, affected by tissue processing

• Mass spectrometry-based quantification:

  • Selected/Multiple Reaction Monitoring (SRM/MRM)

  • Absolute quantification using isotope-labeled peptide standards

  • Highly accurate and specific

  • Can distinguish between protein isoforms and modifications

  • Benefits: Highest accuracy, modification-specific quantification

  • Limitations: Expensive equipment, complex sample preparation

• Comparison of quantification methods:

The optimal technique depends on specific research questions, available equipment, and required sensitivity/specificity.

How should I optimize immunohistochemistry conditions for Os01g0141000 antibodies in plant tissues?

Immunohistochemistry (IHC) in plant tissues presents unique challenges due to cell walls and tissue-specific fixation requirements:

• Tissue preparation optimization:

  • Test different fixatives (e.g., 4% paraformaldehyde, Carnoy's, FAA)

  • Optimize embedding medium (paraffin vs. cryosectioning)

  • Section thickness (typically 5-10μm for paraffin, 10-20μm for cryo)

  • Antigen retrieval methods (critical for accessing nuclear proteins)

• Antibody validation approaches:

  • Genetic validation: Compare wild-type and Os01g0141000 knockout tissues

  • Peptide competition: Pre-incubate antibody with excess Os01g0141000 peptide

  • Orthogonal validation: Compare IHC pattern with in situ hybridization

  • Multiple antibody approach: Use different antibodies targeting distinct epitopes

• Protocol optimization table:

• Plant-specific considerations:

  • Cell wall permeabilization may require additional enzymatic treatment

  • Autofluorescence can be problematic (test quenching methods)

  • Tissue-specific fixation requirements may vary

  • Nuclear proteins like transcription factors may require special nuclear permeabilization

• Quantification approaches:

  • Use consistent acquisition settings for comparative analysis

  • Include internal reference standards

  • Apply automated image analysis with appropriate thresholding

  • Report both signal intensity and percent positive cells/area

Careful optimization and validation are essential for obtaining reliable and reproducible IHC results with Os01g0141000 antibodies in plant tissues.

How can I troubleshoot weak or absent signal when using Os01g0141000 antibodies?

When encountering detection problems with Os01g0141000 antibodies, systematically evaluate these factors:

• Antibody-related issues:

  • Epitope accessibility: The epitope may be masked by protein conformation or interactions

  • Antibody quality: Verify antibody quality with a positive control (recombinant protein)

  • Antibody concentration: Test a range of concentrations (consider 2-5 fold increases)

  • Incubation conditions: Extend incubation time (overnight at 4°C) or adjust temperature

  • Antibody storage: Improper storage may cause degradation; aliquot to avoid freeze-thaw cycles

• Sample-related factors:

  • Protein expression level: Os01g0141000 may be expressed at low levels in your sample

  • Protein degradation: Add fresh protease inhibitors during extraction

  • Tissue-specific expression: Verify expression in your tissue type with transcriptomic data

  • Developmental timing: Expression may vary with developmental stage

  • Stress conditions: Consider whether stress treatments affect expression

• Technical optimizations:

  • Sample buffer: Adjust detergent concentration for better protein extraction

  • Antigen retrieval: Test different methods for IHC/IF applications

  • Signal amplification: Use more sensitive detection systems (enhanced ECL, TSA)

  • Reducing background: Optimize blocking conditions and washing steps

  • Transfer efficiency: For Western blots, verify transfer with reversible staining

• Methodological approach:

  • Switch techniques: If Western blot fails, try immunoprecipitation followed by Western

  • Enrichment: Consider fractionation to concentrate the protein (nuclear extraction)

  • Alternative antibody: Test antibodies targeting different epitopes of Os01g0141000

  • Alternative detection method: Try fluorescent secondary antibodies instead of HRP

• Systematic troubleshooting table:

Document all troubleshooting steps systematically to identify the most effective solution.

How can I develop a quantitative ELISA for Os01g0141000 protein?

Developing a quantitative ELISA for Os01g0141000 requires careful design and optimization:

• ELISA format selection:

  • Sandwich ELISA: Requires two antibodies recognizing different epitopes (highest specificity)

  • Direct ELISA: Antigen directly coated on plate (simpler but less specific)

  • Competitive ELISA: For small proteins or peptides (complex but can be highly sensitive)

• Materials required:

  • Capture antibody: Highly specific for Os01g0141000 (monoclonal preferred)

  • Detection antibody: Against different epitope, enzyme-conjugated or biotinylated

  • Standard: Purified recombinant Os01g0141000 protein

  • Sample preparation protocol: Optimized for plant tissues

  • Microplate: High-binding 96-well plate

• Sandwich ELISA development protocol:

  a) Antibody pair screening:

  • Test different antibody combinations (different epitopes)

  • Optimize antibody concentrations with checkerboard titration

  • Select pair with highest sensitivity and lowest background

  b) Assay optimization:

  • Coating buffer: Test carbonite/bicarbonate (pH 9.6) vs. PBS (pH 7.4)

  • Blocking buffer: Test BSA, casein, and commercial blockers

  • Sample diluent: Optimize to minimize matrix effects

  • Incubation times and temperatures

  • Washing conditions: Buffer composition and number of washes

  c) Standard curve preparation:

  • Use purified recombinant Os01g0141000

  • Create 7-8 point standard curve with 2-fold dilutions

  • Include blank control (zero antigen)

• Assay validation parameters:

• Sample preparation considerations:

  • Develop tissue-specific extraction protocols

  • Test different extraction buffers for optimal protein recovery

  • Include protease inhibitors to prevent degradation

  • Consider sample dilution to minimize matrix effects

  • Evaluate need for additional cleanup steps

Based on similar approaches used in plant protein quantification studies , careful optimization of these parameters should yield a reliable ELISA for Os01g0141000 quantification.

How can I use active learning approaches to improve Os01g0141000 antibody binding prediction?

Active learning strategies can enhance antibody-antigen binding prediction for Os01g0141000, as highlighted in recent research :

• Active learning concept for antibody binding prediction:

  • Start with a small labeled dataset of antibody-antigen interactions

  • Use machine learning to predict binding for untested antibody-antigen pairs

  • Intelligently select the most informative new experiments to perform

  • Iteratively update the model with new experimental data

  • Achieve better predictions with fewer experiments

• Implementation strategies for Os01g0141000 antibody development:

  a) Epitope mapping approach:

  • Create peptide library covering Os01g0141000 sequence

  • Test initial subset of peptides against candidate antibodies

  • Use model to predict binding for untested peptides

  • Select highest uncertainty predictions for next round of testing

  • Iterate until optimal epitope identification is achieved

  b) Antibody optimization approach:

  • Start with panel of candidate antibodies

  • Test subset against Os01g0141000 variants

  • Predict performance of untested antibody-variant pairs

  • Select most informative new experiments

  • Identify antibodies with broadest specificity and highest affinity

• Algorithm comparison based on research findings :

• Application to Os01g0141000 research challenges:

  • Characterizing antibody performance across rice varieties

  • Predicting cross-reactivity with related AP2/ERF proteins

  • Optimizing antibody selection for specific applications

  • Identifying antibodies that maintain binding despite post-translational modifications

• Implementation recommendations:

  • Collaborate with computational biologists for model development

  • Use high-throughput screening platforms for initial data generation

  • Develop standardized binding assays for consistent measurements

  • Share data openly to improve community-wide prediction models

Active learning approaches can significantly reduce experimental costs while improving the quality of antibodies selected for Os01g0141000 detection and characterization .

How do Os01g0141000 antibodies compare to other methods for studying this protein in vivo?

Various approaches exist for studying Os01g0141000 in vivo, each with distinct advantages and limitations:

• Antibody-based approaches:

  • Immunolocalization: Reveals spatial distribution in tissues

  • Western blotting: Detects protein levels and modifications

  • Immunoprecipitation: Isolates protein complexes

  • Advantages: Studies endogenous protein, detects PTMs, works in any genetic background

  • Limitations: Specificity concerns, cannot track dynamics in real-time

• Fluorescent protein tagging:

  • Approach: Create Os01g0141000-GFP/RFP fusion proteins

  • Applications: Live imaging, protein dynamics, protein interactions (FRET)

  • Advantages: Real-time tracking, no fixation artifacts, dynamic studies

  • Limitations: Tag may alter function, overexpression effects, requires transformation

• CRISPR-based approaches:

  • CRISPRi/CRISPRa: Modulate endogenous expression

  • CRISPR-Cas9 editing: Create knockout/knockin lines

  • Advantages: Precise genetic manipulation, studies gene function

  • Limitations: Off-target effects, may not reveal protein interactions

• Comparison table of approaches:

• Complementary approach recommendations:

  • Validate antibody findings with orthogonal methods

  • Combine antibody detection with genetic approaches

  • Use antibodies to validate results from tagged protein studies

  • Integrate data from multiple approaches for comprehensive understanding

• Decision factors for method selection:

  • Research question specificity

  • Available facilities and expertise

  • Temporal vs. spatial resolution needs

  • Whether protein modifications are important

  • Need for dynamic vs. static information

The optimal approach often involves combining multiple methods to overcome the limitations of each individual technique.

How can I apply lessons from therapeutic antibody development to improve Os01g0141000 antibody design?

Principles from therapeutic antibody development can enhance research antibodies against Os01g0141000:

• Key lessons from therapeutic antibody development :

  • Combination approaches: Non-competing antibodies against different epitopes provide better coverage

  • Epitope mapping: Detailed epitope characterization improves specificity

  • Germline-like sequences: Antibodies with fewer somatic mutations may show better stability

  • Developability assessment: Early screening for aggregation and off-target binding

  • Cross-reactivity profiling: Comprehensive testing against similar proteins

• Application to Os01g0141000 antibody design:

  a) Multiple epitope targeting:

  • Develop antibodies against both AP2/ERF and B3 domains

  • Create antibody pairs that don't compete for binding

  • Use in combination for enhanced detection specificity

  b) Comprehensive specificity screening:

  • Test against membrane proteome arrays to identify cross-reactivity

  • Screen against related AP2/ERF proteins in rice

  • Evaluate binding to proteins from other plant species

  • Document cross-reactivity profiles comprehensively

  c) Structural optimization:

  • Use computational modeling to identify stable frameworks

  • Select antibody clones with favorable biophysical properties

  • Engineer stability-enhancing modifications if needed

• Advanced engineering approaches:

• Quality control improvements:

  • Implement therapeutic-grade analytical characterization

  • Establish reference standards for batch-to-batch comparison

  • Document all validation data comprehensively

  • Ensure reproducible manufacturing processes

• Validation strategy:

  • Define clear target product profile

  • Establish quantitative acceptance criteria

  • Validate across multiple applications

  • Test in relevant biological contexts

By applying rigorous standards from therapeutic antibody development, researchers can create Os01g0141000 antibodies with enhanced specificity, sensitivity, and reproducibility, ultimately improving research outcomes.